Skip to main content
Watch Insiders
FATEHealthcare

Fate Therapeutics Inc (FATE) Insider Trading

In the last 90 days, 2 Fate Therapeutics Inc (FATE) insiders reported no open-market purchases and 2 sales totaling $203,506. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 4, 2026Cindy TahlSee RemarksSale38,800$2.46$95,405
Aug 4, 2026Bahram ValamehrPresident and CEOSale43,947$2.46$108,101
May 20, 2026Cindy TahlSee RemarksSale25,590$1.88$48,084
May 20, 2026Bahram ValamehrPresident and CEOSale28,946$1.88$54,482

Common questions

FATE insider trading FAQ

Are FATE insiders buying or selling?
Over the last 90 days, FATE insiders were net sellers, reporting $0.00 of open-market purchases and $203,506 of sales.
When was the last FATE insider purchase?
No open-market insider purchase of Fate Therapeutics Inc stock was reported in the last 90 days.
Where does FATE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Fate Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.